The company’s upcoming earnings report date is not yet available.
How were SOHM’s earnings last quarter?
SOHM released its earnings results on Jul 17, 2018. The company reported $0 earnings per share for the quarter.
Is SOHM overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does SOHM pay dividends?
SOHM does not currently pay dividends.
What is SOHM’s EPS estimate?
SOHM’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SOHM have?
SOHM has 2,710,611,000 shares outstanding.
What happened to SOHM’s price movement after its last earnings report?
SOHM reported an EPS of $0 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of SOHM?
Currently, no hedge funds are holding shares in SHMN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SOHM
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.